EUVIMEDEUVIMED entdecken
Crossref

A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis

Ting Zhao, Bokai Gong, Shiqin Luo, Rongping Zhang, Ling Zhang, Yuan Huang, Huile Gao, Tao Gong

Acta Biomaterialia · 2023-09 · 167 · 574-582

DOI: 10.1016/j.actbio.2023.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-09. Verfasst von Ting Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisAnimalsMiceLungFibroblastsFibrosisAzo CompoundsPyridones

Stichwörter der Autor:innen

Activated fibroblastsFibroblastic fociHypoxiaIdiopathic pulmonary fibrosisPirfenidone

Substanzen

azobenzeneAzo CompoundspirfenidonePyridones

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, T., Gong, B., Luo, S., Zhang, R., Zhang, L., Huang, Y., Gao, H., & Gong, T. (2023). A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis. Acta Biomaterialia, 167, 574-582. https://doi.org/10.1016/j.actbio.2023.06.024

Vancouver

Zhao T, Gong B, Luo S, Zhang R, Zhang L, Huang Y, et al. A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis. Acta Biomaterialia. 2023;167:574-582. doi:10.1016/j.actbio.2023.06.024

BibTeX
@article{Zhao2023,
  author = {Zhao, Ting and Gong, Bokai and Luo, Shiqin and Zhang, Rongping and Zhang, Ling and Huang, Yuan and Gao, Huile and Gong, Tao},
  title = {A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {167},
  pages = {574--582},
  doi = {10.1016/j.actbio.2023.06.024}
}
Kostenlos starten →